StockDrifts LogoStockDrifts

Kissei Pharmaceutical Co., Ltd. 4547

Company
キッセイ薬品工業株式会社Kissei Pharmaceutical Co., Ltd.
Investors
7
Buys
6
Total Value
¥16.2B ($104.4M)
Avg Return
+54.94%
Last Filing
2024-05-20

Kissei Pharmaceutical Co., Ltd. (4547) has 6 disclosed large-shareholding filings and 4 disclosed disposals on record, filed by 7 distinct investors. Together those filings cover ¥16.2B ($104.4M) in reported transaction value. The earliest filing StockDrifts holds for Kissei Pharmaceutical Co., Ltd. is dated 2021-03-22; the most recent is 2024-05-20. All of it is parsed from EDINET large-shareholding (5%+) reports, the official disclosure system operated by the Financial Services Agency (Japan). Across these filings the average return since disclosure is +54.94%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

DateTypeSourceInsiderPurposeSharesPrice at filingReturnValue
2024-05-20BUYunknown
ブランデス・インベストメント・パートナーズ・エル・ピー(Brandes Investment Partners, L.P.)
Brandes Investment Partners, L.P.
other2.5M¥3,160+50.3%¥8.0B ($51.8M)
2024-03-22BUYnegotiated
株式会社長野銀行
Nagano Bank, Ltd.
strategic0¥3,575+32.9%-
2024-03-22BUYnegotiated
株式会社八十二銀行
The Hachijuni Bank, Ltd.
strategic2.2M¥3,575+32.9%¥7.8B ($50.3M)
2024-03-22BUYnegotiated
八十二リース株式会社
Eighty Two Lease Co., Ltd.
strategic137¥3,575+32.9%¥490K ($3K)
2024-01-05BUYMarket Buy
株式会社八十二銀行
The Hachijuni Bank, Ltd.
strategic2.3M¥3,165+50.1%¥359M ($2.3M)
2024-01-05BUYMarket Buy
八十二リース株式会社
Eighty Two Lease Co., Ltd.
strategic137¥3,165+50.1%¥434K ($3K)
2024-01-05SELLMarket Buy
株式会社長野銀行
Nagano Bank, Ltd.
strategic461.8K¥3,165-50.1%¥1.9B ($12.4M)
2023-06-08BUYnegotiated
八十二リース株式会社
Eighty Two Lease Co., Ltd.
strategic137¥2,871+65.5%¥393K ($3K)
2023-06-08BUYnegotiated
株式会社長野銀行
Nagano Bank, Ltd.
strategic1.1M¥2,871+65.5%¥3.2B ($20.9M)
2023-06-08BUYnegotiated
株式会社八十二銀行
The Hachijuni Bank, Ltd.
strategic2.3M¥2,871+65.5%¥6.6B ($42.6M)
2022-04-21SELLMarket Buy
第一生命保険株式会社
The Dai-ichi Life Insurance Company, Limited
passive2.5M¥2,466-92.6%¥1.3B ($8.7M)
2021-03-22SELLunknown
アセットマネジメントOne株式会社
Asset Management One Co., Ltd.
other953.6K¥2,401.149-97.8%¥361M ($2.3M)
2021-03-22SELLunknown
株式会社みずほ銀行
Mizuho Bank, Ltd.
strategic1.2M¥2,401.149-97.8%¥1.2B ($8.0M)

Frequently asked questions

Who has been buying Kissei Pharmaceutical Co., Ltd. stock?
7 distinct investors have filed 6 disclosed large-shareholding filings in Kissei Pharmaceutical Co., Ltd. (4547), most recently on 2024-05-20. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kissei Pharmaceutical Co., Ltd. have?
Kissei Pharmaceutical Co., Ltd. has 6 buy-side and 4 sell-side disclosures on record, covering ¥16.2B ($104.4M) in total reported value, spanning 2021-03-22 to 2024-05-20.
Where does StockDrifts get Kissei Pharmaceutical Co., Ltd. insider data?
From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.
Do insider buys in Japanese stocks predict returns?
Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Source filings

Every trade listed above is disclosed in EDINET large-shareholding (5%+) reports, filed with the Financial Services Agency (Japan). View the original EDINET filings for Kissei Pharmaceutical Co., Ltd.. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.